furothiazole has been researched along with Bladder Cancer in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Davis, BB; Mattammal, MB; Palmier, MO; Zenser, TV | 1 |
| Bryan, GT; Ertürk, E; Headley, DB; Klopp, RG; Michie, PM | 1 |
| Bryan, GT; Cohen, SM; Headley, DB | 1 |
3 other study(ies) available for furothiazole and Bladder Cancer
| Article | Year |
|---|---|
Metabolic activation of the carcinogen N-[4-(5-nitro-2-furyl)-2-thiazolyl]acetamide by prostaglandin H synthase.
Topics: Acetylation; Animals; Biotransformation; Carcinogens; DNA; FANFT; Glutathione; In Vitro Techniques; Kidney Neoplasms; Nitrofurans; Prostaglandin-Endoperoxide Synthases; Protein Binding; Rats; Urinary Bladder Neoplasms | 1984 |
Temporal comparisons of immune status and target organ histology in mice fed carcinogenic 5-nitrofurans and their nornitro analogs.
Topics: Animals; Antibody Formation; Carcinogens; Diet; FANFT; Female; Furans; Immunity, Cellular; Leukemia, Experimental; Lymphoid Tissue; Mice; Mice, Inbred BALB C; Neoplasms, Experimental; Nitrofurans; Thiazoles; Time Factors; Urinary Bladder Neoplasms | 1981 |
Suppression of antibody-mediated and cell-mediated murine immunity by the carcinogen N-[4-(5-nitro-2-furyl)-2-thiazolyl]acetamide.
Topics: Animals; Antibody-Producing Cells; Carcinogens; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Graft vs Host Reaction; Immunity; Immunity, Cellular; Immunosuppressive Agents; Leukemia, Experimental; Leukemia, Lymphoid; Mice; Mice, Inbred BALB C; Neoplasms, Experimental; Nitrofurans; Thiazoles; Urinary Bladder Neoplasms | 1977 |